Latest HCA news and sentiment

The Manufacturers Life Insurance Company Acquires New Position in HCA Healthcare, Inc. $HCA

Ieq Capital LLC Invests $1.25 Million in HCA Healthcare, Inc. $HCA

Ieq Capital LLC has made a new investment of $1.25 million in HCA Healthcare, Inc., acquiring 3,216 shares. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 62.73% of HCA's stock. HCA Healthcare recently reported strong quarterly earnings and revenue, exceeding analyst expectations, and declared a quarterly dividend of $0.78 per share.

12,900 Shares in HCA Healthcare, Inc. $HCA Acquired by Element Capital Management LLC

Element Capital Management LLC recently acquired a new stake of 12,900 shares in HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $5.03 million, making it their 29th largest position. Other institutional investors have also adjusted their holdings in HCA Healthcare, which reported strong quarterly earnings and announced a quarterly dividend of $0.78 per share. Analysts generally rate HCA Healthcare as a "Moderate Buy" with a consensus target price of $462.64.

Lakewood Capital Management LP Acquires New Shares in HCA Healthcare, Inc. $HCA

Lakewood Capital Management LP has acquired 38,500 shares of HCA Healthcare, Inc. worth approximately $15.0 million during the second quarter, making it one of many institutional investors with a stake in the company. HCA Healthcare recently reported strong quarterly earnings, beating analyst expectations with $7.59 EPS and $20.23 billion in revenue, an 8.7% increase year-over-year. Analysts maintain a "Moderate Buy" consensus for HCA Healthcare, with an average price target of $462.64.

OMERS ADMINISTRATION Corp Makes New Investment in HCA Healthcare, Inc. $HCA

OMERS ADMINISTRATION Corp has acquired a new stake of 12,393 shares in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, valued at approximately $4.83 million. Other institutional investors have also recently increased their holdings in HCA Healthcare. The company reported strong Q2 earnings, beating analyst estimates with $7.59 EPS and $20.23 billion in revenue, and announced a quarterly dividend of $0.78 per share.

Osmosis Investment Management UK Ltd Makes New $1.79 Million Investment in HCA Healthcare, Inc. $HCA

Osmosis Investment Management UK Ltd has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) by purchasing 4,602 shares valued at approximately $1.79 million during the second quarter. Other institutional investors have also adjusted their positions in the company, which has an average analyst rating of "Moderate Buy" and a target price of $462.64. HCA Healthcare recently reported strong quarterly earnings, topping analyst estimates, and announced a quarterly dividend.

Meiji Yasuda Asset Management Co Ltd. Buys New Stake in HCA Healthcare, Inc. $HCA

Meiji Yasuda Asset Management Co Ltd. has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 2,555 shares valued at approximately $996,000. Other institutional investors have also adjusted their positions in the company, which recently reported strong quarterly earnings and announced a quarterly dividend. Analysts currently have a "Moderate Buy" rating for HCA Healthcare with an average target price of $462.64.

10,364 Shares in HCA Healthcare, Inc. $HCA Acquired by Commerce Bank

Commerce Bank has acquired 10,364 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $4,041,000 during the second quarter. Other institutional investors have also adjusted their holdings in HCA Healthcare, which has a market cap of $92.92 billion and recently declared a quarterly dividend of $0.78 per share. Analysts have a "Moderate Buy" consensus rating for HCA with an average target price of $462.64.

Cetera Trust Company N.A Purchases New Position in HCA Healthcare, Inc. $HCA

Cetera Trust Company N.A. has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 3,023 shares valued at approximately $1.18 million. This investment comes amidst significant activity from other institutional investors, with BlackRock Inc. and Norges Bank also making substantial new purchases, and Viking Global Investors LP and Northwestern Mutual Wealth Management Co. increasing their holdings. Analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare, with an average price target of $462.64, as the company recently reported strong quarterly earnings and declared a quarterly dividend.

Cibc World Market Inc. Makes New $14.61 Million Investment in HCA Healthcare, Inc. $HCA

Cibc World Market Inc. has made a new investment of $14.61 million in HCA Healthcare, Inc., acquiring 37,460 shares during the second quarter. HCA Healthcare reported strong quarterly earnings, beating analyst expectations with $7.59 EPS and $20.23 billion in revenue, an 8.7% year-over-year increase. The company also declared a quarterly dividend of $0.78 per share, and institutional investors collectively own 62.73% of its stock.

13,092 Shares in HCA Healthcare, Inc. $HCA Bought by Te Ahumairangi Investment Management Ltd

Te Ahumairangi Investment Management Ltd recently acquired 13,092 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $5.1 million. This purchase highlights continued institutional interest in HCA, with such investors collectively owning 62.73% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for HCA, which also reported strong quarterly earnings and declared a quarterly dividend of $0.78 per share.

Quantbot Technologies LP Purchases New Position in HCA Healthcare, Inc. $HCA

Quantbot Technologies LP has acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 8,552 shares valued at approximately $3.334 million. This move is part of broader institutional investment activity, with other firms like Sumitomo Life Insurance Co. and MJP Associates Inc. ADV also adjusting their holdings in the healthcare provider. Analysts have issued a "Moderate Buy" consensus rating for HCA Healthcare, with a target price of $462.64, while the company recently reported strong quarterly earnings and declared a quarterly dividend.

Ally Financial Inc. Acquires Shares of 6,000 HCA Healthcare, Inc. $HCA

Ally Financial Inc. recently acquired 6,000 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $2.339 million, as disclosed in its latest SEC filing. This acquisition is part of broader institutional investment activity in HCA, with other firms like Nomura Asset Management and Sunbelt Securities also adjusting their stakes. Wall Street analysts currently have a "Moderate Buy" consensus rating for HCA Healthcare, with an average price target of $462.64.

Korea Investment CORP Buys Shares of 99,629 HCA Healthcare, Inc. $HCA

Kiltearn Partners LLP Acquires Shares of 37,314 HCA Healthcare, Inc. $HCA

Kiltearn Partners LLP has acquired a new position of 37,314 shares in HCA Healthcare, valued at approximately $14.5 million, making it the fund's 9th largest holding. Institutional investors now own 62.73% of HCA. Despite several analysts lowering their price targets, the company maintains a "Moderate Buy" consensus rating with an average target of $462.64, having recently reported strong quarterly earnings and declared a $0.78 per share dividend.

Kendall Capital Management Invests $1.40 Million in HCA Healthcare, Inc. $HCA

Kendall Capital Management has acquired a new position in HCA Healthcare, Inc. worth approximately $1.40 million. Institutional investors hold 62.73% of the company, and analysts generally rate the stock a "Moderate Buy" with an average target price of $462.64. HCA Healthcare recently reported strong quarterly revenues and earnings, exceeding expectations, and declared a quarterly dividend.

Elevation Point Wealth Partners LLC Acquires New Position in HCA Healthcare, Inc. $HCA

Evolve Private Wealth LLC Invests $3.21 Million in HCA Healthcare, Inc. $HCA

Evolve Private Wealth LLC has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 8,224 shares valued at approximately $3.21 million. This investment comes as several other institutional investors also adjusted their positions in the healthcare company. HCA Healthcare recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

Harber Asset Management LLC Invests $5.04 Million in HCA Healthcare, Inc. $HCA

Harber Asset Management LLC initiated a new position in HCA Healthcare, Inc. by purchasing 12,930 shares valued at $5.04 million, making it 3% of the firm's portfolio. HCA Healthcare exceeded quarterly earnings expectations with $7.59 EPS and $20.23 billion in revenue, also declaring a quarterly dividend of $0.78. Analysts maintain a "Moderate Buy" consensus with an average price target of $462.64 for the company.

Advisors Capital Management LLC Buys Shares of 6,507 HCA Healthcare, Inc. $HCA

10,563 Shares in HCA Healthcare, Inc. $HCA Bought by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG acquired 10,563 shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, valued at approximately $4.1 million, contributing to institutional investors owning 62.73% of the company. HCA Healthcare reported strong quarterly earnings of $7.59 per share, exceeding estimates, and declared a quarterly dividend of $0.78 per share. Despite several analysts lowering price targets, the company maintains a consensus "Moderate Buy" rating with an average price target of $462.64.

HCA Healthcare Jumps 6.0% After JP Morgan Maintains Neutral

HCA Healthcare shares surged 6.0% to $430.79 on Friday, despite JP Morgan cutting its price target from $490 to $425 and maintaining a Neutral rating. The unexpected rally suggests investors may be looking beyond the analyst's more conservative outlook, possibly anticipating stronger operational performance or improved industry fundamentals. This divergence highlights the complexity of market sentiment around HCA, a major hospital operator, as trading volume reached 750,059 shares.